PMC:7317273 / 16165-16328
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T111","span":{"begin":75,"end":88},"obj":"Body_part"},{"id":"T112","span":{"begin":116,"end":121},"obj":"Body_part"},{"id":"T113","span":{"begin":136,"end":141},"obj":"Body_part"},{"id":"T114","span":{"begin":154,"end":162},"obj":"Body_part"},{"id":"T115","span":{"begin":157,"end":162},"obj":"Body_part"}],"attributes":[{"id":"A111","pred":"fma_id","subj":"T111","obj":"http://purl.org/sig/ont/fma/fma9825"},{"id":"A112","pred":"fma_id","subj":"T112","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A113","pred":"fma_id","subj":"T113","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A114","pred":"fma_id","subj":"T114","obj":"http://purl.org/sig/ont/fma/fma63147"},{"id":"A115","pred":"fma_id","subj":"T115","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"After 6 days of infusion, the therapy inhibited the over-activation of the immune system by inhibiting CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T32","span":{"begin":75,"end":88},"obj":"Body_part"}],"attributes":[{"id":"A32","pred":"uberon_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"text":"After 6 days of infusion, the therapy inhibited the over-activation of the immune system by inhibiting CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T180","span":{"begin":57,"end":67},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T181","span":{"begin":75,"end":88},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T182","span":{"begin":109,"end":112},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T183","span":{"begin":114,"end":121},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T184","span":{"begin":129,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T185","span":{"begin":134,"end":141},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T186","span":{"begin":154,"end":162},"obj":"http://purl.obolibrary.org/obo/CL_0000623"}],"text":"After 6 days of infusion, the therapy inhibited the over-activation of the immune system by inhibiting CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"276","span":{"begin":103,"end":108},"obj":"Gene"},{"id":"277","span":{"begin":109,"end":112},"obj":"Gene"},{"id":"278","span":{"begin":123,"end":128},"obj":"Gene"},{"id":"279","span":{"begin":129,"end":132},"obj":"Gene"},{"id":"280","span":{"begin":147,"end":152},"obj":"Gene"}],"attributes":[{"id":"A276","pred":"tao:has_database_id","subj":"276","obj":"Gene:2833"},{"id":"A277","pred":"tao:has_database_id","subj":"277","obj":"Gene:920"},{"id":"A278","pred":"tao:has_database_id","subj":"278","obj":"Gene:2833"},{"id":"A279","pred":"tao:has_database_id","subj":"279","obj":"Gene:925"},{"id":"A280","pred":"tao:has_database_id","subj":"280","obj":"Gene:2833"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"After 6 days of infusion, the therapy inhibited the over-activation of the immune system by inhibiting CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T299","span":{"begin":0,"end":163},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"After 6 days of infusion, the therapy inhibited the over-activation of the immune system by inhibiting CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells."}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T278","span":{"begin":68,"end":70},"obj":"GO:0042116"},{"id":"T279","span":{"begin":75,"end":88},"obj":"UBERON:0002405"},{"id":"T280","span":{"begin":103,"end":108},"obj":"PR:000001207"},{"id":"T281","span":{"begin":109,"end":112},"obj":"PR:000001004"},{"id":"T282","span":{"begin":114,"end":121},"obj":"CL:0000084"},{"id":"T283","span":{"begin":123,"end":128},"obj":"PR:000001207"},{"id":"T284","span":{"begin":134,"end":141},"obj":"CL:0000084"},{"id":"T285","span":{"begin":147,"end":152},"obj":"PR:000001207"}],"text":"After 6 days of infusion, the therapy inhibited the over-activation of the immune system by inhibiting CXCR3+CD4+ T cells, CXCR3+CD8+ T cells, and CXCR3+ NK cells."}